Analytical Chemistry Assays
Analyte | Sample Type | Instrument |
---|---|---|
2-AG(2-Arachidonoylglycerol), AEA(N-arachidonoylethanolamine) | Brain, brain perfusate | HPLC-MS/MS |
4-HPR (N-(4-hydroxyphenyl)-retinamide) | Plasma; Tissue | HPLC-FLD |
5-FU (Fluorouracil) | Cells | HPLC-MS/MS |
8-Hydroxy-2'-deoxyguanosine | Urine; DNA | HPLC-MS/MS |
8-Isoprostaglandin F2 alpha | Urine; Plasma | HPLC-MS/MS |
Acetylcholine | Mouse cortex | HPLC-MS/MS |
AH1S2(iron chelator) | Mouse Plasma | HPLC-MS/MS |
Alpha-tocopheryloxyacetic acid | Plasma | HPLC-MS/MS |
Amino Acids | Cell Culture | HPLC-MS/MS |
AMP423(naphthyl derivative of 2-cyanoaziridine-1-carboxamide) | Formulation Preparation | HPLC-MS |
Aspirin | Plasma | HPLC-MS/MS |
Antalarmin | Plasma | HPLC-MS/MS |
Arginine/Ornithine | Intestine; Colon Tissue | HPLC-FLD |
AZ002S | Mouse Plasma | HPLC-MS/MS |
AZD/Ponatinib | Plasma | HPLC-MS/MS |
Bile acids | Fecal Water; Plasma; Intestinal fluid | HPLC-MS |
Bile acids (parent bile acids and taurine and glycine conjugates) | Gastric fluid | HPLC-MS/MS |
Bixin | Plasma | HPLC-UV |
Buspirone | Plasma | HPLC-MS/MS |
C391 | Plasma | HPLC-UV-MS |
Caffeine/Caffeine metabolites | Plasma | HPLC-UV; HPLC-MS/MS |
Carbendazim | Plasma | HPLC-MS/MS |
Carotenoids | Plasma; Skin | HPLC-FLD |
Celecoxib | Plasma | HPLC-UV |
Ceramide | Cells; plasma; Urine; tissue | *HPLC-MS/MS |
Ceramide-1-Phosphate | Cells; plasma; Urine; tissue | *HPLC-MS/MS |
cGMP | Cell Extract | HPLC-MS/MS |
Chlorophyll | Colon Tissue | HPLC-FLD |
Compound L | Mouse Plasma | HPLC-MS/MS |
Cortisol/6-Hydroxycortisol | Urine | HPLC-UV |
Cortisol/Cortisone | Saliva | HPLC-MS/MS |
Curcumin | Plasma; Urine; Skin | HPLC-UV; HPLC-MS/MS |
Cytarabine + nucleosides | Cells | HPLC-MS/MS |
Dexmedetomidine | Urine | HPLC-MS/MS |
Dextromethorphan (DM)/DM metabolites | Urine | HPLC-FLD |
DFMO (Alpha-difluoromethylornithine) | Plasma; Skin | HPLC-FLD |
Diacylglycerides | Cells; plasma; Urine; tissue | *HPLC-MS/MS |
Dihydrotestosterone | Cytosolic extract | HPLC-MS |
DIM (diindolylmethane) | Urine | HPLC-MS/MS |
Diphenidol | Cell culture media | HPLC-MS/MS |
DITPA (3,5-diiodothyropropionic acid) | Plasma | HPLC-MS/MS |
Dopamine | Mouse Cortex | HPLC-MS/MS |
Doxorubicin | Tissue (mouse tumor) | UPLC-TOF-MSe |
DPC0046 | Plasma | HPLC-MS/MS |
Endocannabinoids | Plasma | *HPLC-MS/MS |
Epinephrine | Mouse cortex | HPLC-MS/MS |
Estrone/Estradiol +13 metabolites | Plasma; urine | HPLC-MS/MS |
Fatty acids | Plasma | HPLC-MS/MS |
FICZ(6-Formylindolo(3,2-b)carbazole) | PBS | HPLC-MS |
GABA (gamma-aminobutyric acid) | Mouse Cortex; Urine | HPLC-MS/MS |
gamma-Glutamylcysteine | Cell extract | HPLC-FLD |
Gemcitabine Triphosphate | Blood Lymphocytes; Cell Extract | HPLC-UV |
Gemcitabine | Plasma; Tissue; Cell Extract | HPLC-UV; HPLC-MS/MS |
Genistein | Plasma | HPLC-MS/MS |
Glutamate | Mouse Cortex | HPLC-MS/MS |
Glyoxal, Methyl glyoxal | Cell extract | GC-MS |
5-,8-,11-,12-,15-,20-HETEs (hydroperoxyeicosatetraenoic acid) | Lung Tissue | HPLC-MS/MS |
Hexosylceramide/LactosylCer | Cells; plasma; Urine; tissue | *HPLC-MS/MS |
HPMA(N-(2-Hydroxypropyl)methacrylamide), SPMA (S-phenyl mercapturic acid), HMPMA(3-hydroxy-1-methylpropylmercapturic acid) | Urine | HPLC-MS/MS |
Imexon | Plasma | HPLC-UV |
Iron | Cell Extract | AAS |
Isothiocyanate-glutathione conjugates | Cultured cells | HPLC-MS/MS |
Kynurenine Pathway Metabolites*** | Urine, plasma, liver | HPLC-MS/MS |
LTE4(Leukotriene E4) | Urine | HPLC-MS/MS |
Limonene | Plasma; breast tissue, adipose tissue | HPLC-MS/MS; GC-MS |
Losartan/Losartan Metabolites | Urine; Plasma | HPLC-UV; HPLC-MS/MS |
Malondialdehyde | Cell extract | GC-MS |
Melphalan/Melphalan analogues | Dosing Preparation | HPLC-MS/MS |
Metformin | Plasma; Cell culture media; Tissue | HPLC-MS/MS |
Methyl-4-aminosalicylate | Pure Standard | HPLC-UV |
Metronidazole | Cells | HPLC-MS/MS |
Midazolam/ Midazolam Metabolites | Plasma | HPLC-MS/MS |
Napthazarin | Pure Standard | HPLC-UV-MS/MS |
Nitotinic acid/Nicotinamide | Plasma | HPLC-MS/MS |
Nitrite | Cell culture media | HPLC-FLD |
Norepinephrine | Mouse cortex | HPLC-MS/MS |
NPA-093 | Plasma | HPLC-UV |
Nucleoside Triphosphates/deoxyNucleoside Triphosphates | Cell extract | HPLC-MS/MS |
Omeprazole/Metabolites | Plasma | HPLC-MS/MS |
Oxylipins(69 individual**) | Plasma | UPLC-TOF-MS |
Pazopanib | Plasma | HPLC-MS/MS |
Pemetrexed (Alimta®) | Plasma; IP fluid | HPLC-MS/MS |
Pentosidine | Plasma | HPLC-FLD |
PGE-M | Urine | HPLC-MS/MS |
Phenethylamine | Urine | HPLC-MS/MS |
Phthalates (mono- and di-butyl phthalate) | Plasma; Tissue | HPLC-MS/MS |
PHT-427 (Akt/phosphatidylinositide-dependent Protein Kinase 1 Pleckstrin Homology Domain Inhibitor) | Plasma; Tissue | HPLC-UV; HPLC-MS/MS |
PhytoCeramide | Yeast | *HPLC-MS/MS |
PMIP (therapeutic peptide) | Plasma | HPLC-MS/MS |
Polyamines | Plasma; Tissue | HPLC-FLD |
Psorospermin methyl ether | Plasma | HPLC-UV |
PX-12(1-methylpropyl 2-imidazolyl disulfide) | Plasma | HPLC-UV; HPLC-MS/MS |
Quercetin | Plasma; skin | HPLC-MS/MS |
Radicicol | Plasma | HPLC-MS/MS |
Rapamycin | Whole blood | HPLC-MS/MS |
Resveratrol | Plasma; Tissue | HPLC-MS/MS |
Retinols(Retinol, all-trans retinoic acid, 9-cis retinoic acid) | Plasma; Skin, Mouse Tissue | HPLC-FLD/HPLC-MS/MS |
Selenium | Plasma, prostate tissue | AA |
Serotonin | Plasma; Tissue; Urine | HPLC-MS/MS |
SGM45 | Mouse Plasma | HPLC-MS/MS |
Sphingosine/Sphinogsine-1-P | Cells; plasma; Urine; tissue | *HPLC-MS/MS |
Sphingomyelin | Cells; plasma; Urine; tissue | *HPLC-MS/MS |
Sulindac/Sulindac metabolites | Plasma; Breast Fluid; Skin | HPLC-MS/MS |
Targretin | Plasma | HPLC-FLD |
Taurine | Urine | HPLC-MS/MS |
Tea Catechins | Plasma; Urine | HPLC-EC |
Testosterone | Plasma | HPLC-MS/MS |
TC1S2(iron chelator) | Mouse Plasma | HPLC-MS/MS |
TC4G6(iron chelator) | Mouse Plasma | HPLC-MS/MS |
Thyroxine/Triiodothyroxine | Plasma | HPLC-MS/MS |
Tocopherol/Tocopherol succinate | Plasma; Tissue | HPLC-FLD |
UA8967 | Plasma | HPLC-MS/MS |
Withaferin analogues | Plasma | HPLC-MS/MS |
Wortmannin analogues | Plasma; Bile | HPLC-MS/MS |
Zileuton | Plasma | HPLC-MS/MS |
DISCOVERY (untargeted) Metabolomics and Lipidomics –
Analysis is performed on most sample types listed above. The analysis is performed on a Thermo Vanquish Dual UPLC/Exploris 480 Orbi(producing HRAM spectra). Chromatographic strategies include Reverse Phase and HILIC (With lipid specific chromatography for Lipidomics). Sample preparation is available through the resource. Samples are processed utilizing Thermo Compound Discoverer and/or Lipid Search Software, statistical analysis utilizes R and Metaboanalyst. As this is typically a tailored analysis please inquire with ACSR for a consultation to discuss projects.
* = available through Sub-core
** = 9-HOTrE, 13-HOTrE, 13-oxo-ODE, 9-oxo-ODE, 13-HODE, 9-HODE, 12(13)-EpOME, 9(10)-EpOME, EKODE, 12,13-DiHOME, 9,10-DiHOME, 15-deoxy-Prostaglandin J2, 15-HEPE, 8-HEPE, 12-HEPE, 5-HEPE, 17(18)-EpETE, 15-oxo-ETE, 14(15)-EpETE, 11(12)-EpETE, 8(9)-EpETE, 12-oxo-ETE, 5-oxo-ETE, 20-HETE, 15-HETE, 11-HETE, 8-HETE, 12-HETE, 9-HETE, 5-HETE, 14(15)-EET, 11(12)-EET, 8(9)-EET, 5(6)-EET, 15(S)-HETrE, Prostaglandin J2, Prostaglandin B2, 8,15-DiHETE, 6-trans-Leukotriene B4, 5,15-DiHETE, 17,18-DiHET, Leukotriene B4, 14,15-DiHETE, 5,6-DiHETE, 14,15-DiHET, Leukotriene B3, 11,12-DiHET, 8,9-DiHET, 5,6-DiHET, 17-HDHA, 19(20)-EpDPA, 16(17)-EpDPA, 13(14)-EpDPA, 10(11)-EpDPA, 7(8)-EpDPA, Prostaglandin E3, Prostaglandin D3, 20-OH-Leukotriene B4, Prostaglandin E2, Prostaglandin D2, Lipoxin A4, Prostaglandin F2a, Prostaglandin E1, Prostaglandin D1, 19,20-DiHDPE, 20-COOH-LTB4, 6-keto-PGF1a, TXB2, Resolvin D1
*** = 3-hydroxyanthranilic acid, quinolinic acid, anthranilic acid, L-tryptophan, L-kynurenine, kynurenic acid, 3-hydroxykynurenine, cinnabarinic acid, xanthurenic acid, N-formylkynurenine, picolinic acid, 5-hydroxytryptophan, serotonin, melatonin, tryptamine, glutamic acid, dopamine
To build a project, get a quote, or order a service within iLab:
- Step 1: Select “About Our Core” to learn more about this Shared Resource.
- Step 2: Login or sign up for an iLab account here, at the University of Arizona. For login help, email iLab-support@agilent.com.
- Step 3: Once the login step is completed, obtaining prices, services and scheduling is available within the iLab system.
Please remember to acknowledge the Cancer Center Support Grant (P30 CA023074) when publishing manuscripts or abstracts that utilized the services of the University of Arizona Cancer Center’s Shared Resources and/or were derived from CCSG pilot funds. Suggested language: "Research reported in this [publication/press release] was supported by the National Cancer Institute of the National Institutes of Health under award number P30 CA023074.
Contact
Potential users, especially first-time users, are encouraged to personally contact ACSR service personnel for instructions on how to access all the services of the Analytical Chemistry Shared Resource.
Please contact Dr. Snider by phone or email. After a short discussion about your project, the service request form can be submitted to the ACSR and a realistic timeline can be projected.
All University of Arizona Cancer Center members have access to the Analytical Chemistry Shared Resource. The service is provided according to the following University of Arizona Cancer Center priority guidelines
- University of Arizona Cancer Center members with peer-reviewed extramural funding;
- New University of Arizona Cancer Center investigators with University of Arizona Cancer Center pilot project or developmental funding;
- University of Arizona Cancer Center members with other funding sources;
- Peer-reviewed, funded non-members at University of Arizona if sufficient time/resources are available to accommodate requested service.